The Board approved financials results for the fourth quarter and year ended March 31, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Healthy Investments Limited's board, at its May 29, 2025 meeting, approved audited FY25 results for the company that operates only in portfolio investments. The firm reported no operating revenue, with other income falling to ₹20.86 lakhs from ₹36.23 lakhs in FY24 — a drop of roughly 42%. Profit before tax declined to ₹7.50 lakhs from ₹22.25 lakhs, and the company swung to a net loss of ₹58.77 lakhs (vs a profit of ₹15.09 lakhs last year), primarily hit by a ₹62.79 lakh deferred tax charge. Total comprehensive income turned negative at ₹(45.96) lakhs versus ₹564.34 lakhs in FY24, and EPS fell to ₹(23.99) from ₹6.16. Operating cash flow remained negative at ₹(17.47) lakhs. The statutory auditor issued a clean, unqualified opinion and the 43rd AGM was fixed for June 27, 2025.
FY25 marks a clear deterioration driven by lower investment income and a one-time deferred tax impact, turning the company loss-making at the bottom line. Shareholders should note weak operating cash generation and a very thin equity base (₹24.5 lakhs share capital) that magnifies per-share swings, making near-term earnings volatile.